We are studying whether combining Niraparib with Bevacizumab improves outcomes for patients receiving chemotherapy for advanced ovarian cancer. This trial aims to see if the combination treatment helps patients live longer without their cancer progressing.
Health conditions and diseases that the clinical trial is designed to study and treat.
Ovarian cancer is a type of cancer that begins in the ovaries, and it can also include cancers of the fallopian tubes and peritoneum. It often goes undetected until it has spread within the pelvis and abdomen, making early diagnosis challenging.
Peritoneal carcinoma is a cancer that occurs in the peritoneum, the lining of the abdominal cavity. It is often associated with ovarian cancer and can present similar symptoms.
Fallopian tube cancer is a rare type of cancer that starts in the fallopian tubes, which connect the ovaries to the uterus. It is often diagnosed at an advanced stage and may share symptoms with ovarian cancer.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.